ETFs con mejor rendimiento
Elige el período y la base. El retorno de precio utiliza precios de cierre; el retorno total utiliza la serie ajustada por dividendos (distribuciones reinvertidas). Las cifras plurianuales están anualizadas. Se excluyen fondos con menos de $50M.
| # | ETF | Precio | Hoy | Rentabilidad del período | AUM | Comisión | YTD | |
|---|---|---|---|---|---|---|---|---|
| 1 | BBC Virtus Biotech Clinical Trials ETF | 55.34 | +0.34% | +141.04% | $53.0M | 0.65% | +43.02% | |
| 2 | BIB ProShares Ultra Nasdaq Biotechnology | 123.15 | -0.67% | +121.91% | $107.7M | 1.19% | +55.40% | |
| 3 | SBIO ALPS Medical Breakthroughs ETF | 69.51 | -0.22% | +99.14% | $249.9M | 0.50% | +36.00% | |
| 4 | XBI State Street SPDR S&P Biotech ETF | 168.23 | -0.10% | +87.31% | $11.92B | 0.35% | +38.10% | |
| 5 | GNOM Global X - Genomics & Biotechnology ETF | 67.24 | -0.16% | +82.62% | $95.5M | 0.50% | +48.15% | |
| 6 | CANC Tema Oncology ETF | 44.79 | -0.13% | +67.46% | $216.8M | 0.99% | +29.16% | |
| 7 | BBP Virtus Biotech ETF | 108.71 | +0.04% | +60.83% | $119.9M | 0.34% | +35.97% | |
| 8 | FBT First Trust NYSE Arca Biotechnology Index Fund | 273.91 | +0.68% | +58.26% | $2.97B | 0.55% | +31.74% | |
| 9 | IBBQ Invesco Nasdaq Biotechnology ETF | 36.45 | -0.33% | +55.55% | $95.3M | 0.19% | +28.77% | |
| 10 | IBB iShares Biotechnology ETF | 214.80 | -0.20% | +55.43% | $10.84B | 0.44% | +27.53% | |
| 11 | XPH State Street SPDR S&P Pharmaceuticals ETF | 72.41 | -0.55% | +54.52% | $584.4M | 0.35% | +29.99% | |
| 12 | RXL ProShares Ultra Health Care | 61.00 | -2.29% | +50.80% | $95.4M | 1.07% | +20.50% | |
| 13 | BBH VanEck Biotech ETF | 241.99 | -0.21% | +46.62% | $481.5M | 0.35% | +28.22% | |
| 14 | PBE Invesco Biotechnology & Genome ETF | 98.54 | +0.46% | +44.55% | $404.8M | 0.58% | +19.40% | |
| 15 | PINK Simplify Health Care ETF | 39.99 | -0.37% | +32.08% | $383.1M | 0.51% | +9.67% | |
| 16 | HRTS Tema Heart & Health ETF | 38.06 | -1.05% | +30.54% | $57.3M | 0.99% | +9.01% | |
| 17 | SURI Simplify Propel Opportunities ETF | 20.53 | +0.29% | +28.99% | $87.2M | 2.82% | +22.72% |
Market data delayed approximately 15–20 minutes unless otherwise indicated. Las clasificaciones ordenan características medibles — nunca son una recomendación de compra o venta.